Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term resistant. Found 11 abstracts

Dotan E, Cohen SJ, Alpaugh KR, Meropol NJ. Circulating Tumor Cells: Evolving Evidence and Future Challenges. The oncologist. 2009 Jan;14(11):1070-82.   PMCID: not NIH funded
Dritschilo A, Huang CH, Rudin CM, Marshall J, Collins B, Dul JL, Zhang CB, Kumar D, Gokhale PC, Ahmad A, Ahmad I, Sherman JW, Kasid UN. Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies. CLINICAL CANCER RESEARCH. 2006 Feb;12(4):1251-9.
Ozols RF. NICE guidelines for ovarian cancer: Recommendations versus standard care. Cancer Investigation. 2004 Jan;22 (5):815-7.
Ozols R. Treatment of gynecologic cancer: The US experience. Tumori. 1999 May;85(3):S5-S11.
Weiss GR, Poggesi I, Rocchetti M, DeMaria D, Mooneyham T, Reilly D, Vitek LV, Whaley F, Patricia E, Von Hoff DD, O'Dwyer P. A phase I and pharmacokinetic study of tallimustine PNU152241 (FCE 24517) in patients with advanced cancer. Clinical Cancer Research. 1998 Jan;4(1):53-9.
Ciaccio PJ, Tew KD. Adaptive response to glutathione S-transferase inhibitors. British Journal of Cancer. 1996 Jul;74:S93-S98.
Lacreta FP, Brennan JM, Hamilton TC, Ozols RF, Odwyer PJ. Stereoselective Pharmacokinetics of L-Buthionine Sr-Sulfoximine in Patients with Cancer. Drug Metabolism and Disposition. 1994 Nov;22(6):835-42.
Speicher LA, Laing N, Barone LR, Robbins JD, Seamon KB, Tew KD. Interaction of an Estramustine Photoaffinity Analog with Cytoskeletal Proteins in Prostate Carcinoma-Cells. Molecular Pharmacology. 1994 Nov;46(5):866-72.
Brennan JM, Odwyer PJ, Ozols RF, Lacreta FP. High-Performance Liquid-Chromatographic Determination of the S- Diastereoisomers and R-Diastereoisomers of L-Buthionine (Sr)- Sulfoximine in Human Plasma and Urine. Journal of Chromatography-Biomedical Applications. 1993 Oct 22;620(1):121-8.
Ozols RF. Role of Carboplatin in Ovarian-Cancer - Current Results and Thoughts for the Future. Acta Obstetricia Et Gynecologica Scandinavica. 1992 Jan;71:75-7.
Perez RP, Handel LM, Hamilton TC. Potentiation of Cisplatin Cytotoxicity in Human Ovarian- Carcinoma Cell-Lines by Trifluoperazine, a Calmodulin Inhibitor. Gynecologic Oncology. 1992 Jul;46(1):82-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term resistant

Last updated on Wednesday, February 05, 2020